Screener
ImmunityBio, Inc. IBRX Derivative, Gain (Loss) on Derivative, Net
Derivative, Gain (Loss) on Derivative, Net at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DerivativeGainLossOnDerivativeNet.
The source filing: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:37 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326110-26-000059
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Change in fair value of related-party convertible note | (236,625) | (42,582) |
| Interest expense – related party | (14,559) | (15,313) |
| Interest expense related to revenue interest liability | (13,871) | (13,534) |
| Change in fair value of derivative liabilities | 1,108 | 5,578 |
| Interest expense | (34) | (18) |
| Other expense, net | (5,917) | (41) |
| Total other expense, net | (562,997) | (65,471) |
| Loss before income taxes and noncontrolling interest | (632,788) | (129,900) |
ITEM 1. FINANCIAL STATEMENTS.
FAQ
- What is ImmunityBio, Inc.'s derivative, gain (loss) on derivative, net?
- ImmunityBio, Inc. (IBRX) reported derivative, gain (loss) on derivative, net of $1.11M in Q1 2026.
- How has ImmunityBio, Inc.'s derivative, gain (loss) on derivative, net changed year-over-year?
- ImmunityBio, Inc.'s derivative, gain (loss) on derivative, net decreased by 80.1% year-over-year, from $5.58M to $1.11M.
- What does derivative, gain (loss) on derivative, net mean?
- This metric tracks the net gain or loss from derivative financial instruments, such as options, swaps, or forward contracts. These instruments are often used for hedging risks or as part of complex financing arrangements. The net result is reported as a non-operating item and can cause significant fluctuations in reported net income.
Ask your AI about ImmunityBio, Inc.'s derivative, gain (loss) on derivative, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude